News
Pharma has so far been exempted from Trump's tariff blitz, which imposed a flat rate of 10% on imports from 5th April and ...
The Advisory Committee on Immunisation Practices (ACIP) has voted to widen the recommendations on the use of RSV shots to ...
Immunotherapy is increasingly becoming standard therapy in cancer, with technology, such as checkpoint inhibitors and cell ...
Greater availability of real-world data and real-world evidence is rapidly changing the landscape of drug development.
The South San Francisco biotech has acquired rights to tralesinidase alfa, an enzyme replacement therapy (ERT) for the ...
A complaint against GSK accusing it of a major breach of the pharma industry's code of practice on prescribing information has been upheld after a review by the Prescription Medicines Code of Practice ...
In one move that will please the drug industry, Trump has promised to do away with the detested 'pill penalty', a shorter ...
Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type ...
Access to UK Biobank data by researchers based in China has sparked headlines in the UK about potential security concerns, ...
The policy was the buzz of the International Society for Health Economics and Outcomes Research (ISPOR) annual European ...
Johnson & Johnson has said it expects to see a $400 million financial hit from President Trump's tariffs, which will be felt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results